The U.S. Food and Drug Administration (FDA) announced the target action date of its review of the sNDA for VTAMA (tapinarof) cream, 1% has changed.

The Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for tapinarof cream, 1% in the treatment of atopic dermatitis in adults and ...

Atopic dermatitis can have a significant impact on quality of life in adolescents, so new efficient treatments are needed to ...

If not controlled with the above measures, your eczema might require prescription treatments like corticosteroids or even ...

Individuals who suffer from atopic dermatitis are three times more likely to develop anxiety, depression and sleep ...

Organon, which is seeking approval of Vtama as a treatment for atopic dermatitis, said the FDA set a new target action date of March 12 for a decision after requesting the final datasets and ...

Explore innovative nutritional and microbial strategies for effectively treating acne, alopecia, and atopic dermatitis.

Thankfully, many skincare brands have taken into account the large segment of the population who struggle with sensitive skin ...

But one ingredient that’s gone viral on TikTok is worth paying attention to: hypochlorous acid. It’s a soothing, potent ...

The substantial correlation between prurigo nodularis (PN) and atopic dermatitis (AD) has been highlighted by a recent ...

Dermavant Sciences has shared positive long-term results for its plaque psoriasis-approved Vtama (tapinarof) cream in adults ...

A new study being presented at this year’s ACAAI Annual Scientific Meeting in Boston showed that elimination diets in the case of atopic dermatitis only mildly improved AD lesions in one-third of the ...